H. Lundbeck A/S (HLBBF)
OTCMKTS
· Delayed Price · Currency is USD
5.35
0.00 (0.00%)
At close: Jun 20, 2025
H. Lundbeck Employees
H. Lundbeck had 5,707 employees as of December 31, 2024. The number of employees increased by 26 or 0.46% compared to the previous year.
Employees
5,707
Change (1Y)
26
Growth (1Y)
0.46%
Revenue / Employee
$583,400
Profits / Employee
$83,604
Market Cap
5.46B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Endo, Inc. | 3,116 |
Elite Pharmaceuticals | 64 |
Tian'an Technology Group | 8 |
Glass House Brands | 374 |
American Oncology Network | 1,914 |
CytoDyn | 9 |
Northwest Biotherapeutics | 25 |
Silence Therapeutics | 116 |
H. Lundbeck News
- 7 days ago - New data demonstrates robust efficacy of Vyepti® (eptinezumab) in otherwise difficult-to-treat patients with severe migraine - Benzinga
- 7 days ago - New data from phase III trial confirms efficacy of Vyepti® (eptinezumab) in Asian population with chronic migraine - Benzinga
- 6 weeks ago - Lundbeck Delivering On The Financials, But Needs Some Positive Clinical Drivers - Seeking Alpha
- 3 months ago - Lundbeck's potential treatment for Multiple System Atrophy granted Orphan Drug Designation in Japan - PRNewsWire
- 6 months ago - Lundbeck's Appreciation Potential Is Closely Tied To A High-Risk Clinical Pipeline (Rating Upgrade) - Seeking Alpha
- 8 months ago - Longboard Pharmaceuticals HSR waiting period expires for Lundbeck deal - Seeking Alpha
- 9 months ago - Longboard Pharma's Lucrative Exit To Lundbeck Another Coup For Management - Seeking Alpha
- 9 months ago - NVIDIA, Trump Media & Technology, Bausch + Lomb, Sirius XM And Other Big Stocks Moving Higher On Monday - Benzinga